Here are some stem cell weekend reads for your enjoyment along with various links and headlines. Some science pubs that caught my eye: Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in […]
TGIF: stem cell weekend reads & links Read More »
How is the stem cell and regenerative medicine biotech sector doing these days and does recent news about specific biotechs such as Capricor suggest issues for the sector more broadly? Capricor had bad news earlier this year related to its stem cells for heart disease program and things just took a turn for the worse
Shot to the heart: J&J punts on Capricor & its cardiac stem cell program Read More »
Can a stem cell clinic business get FDA RMAT designation? At least one announced it was trying, but now seems to have given up. Stem cell clinic business US Stem Cell, Inc. has reportedly announced that it is at least temporarily abandoning its efforts at getting Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. The
US Stem Cell bid for FDA RMAT rejected? Read More »
Late in 2015, one of the pioneering stem cell and regenerative medicine biotechs, Ocata Therapeutics (fka as ACT or Advanced Cell Technology) was acquired by Astellas Pharma. At the time of purchase, Ocata had a number of areas of focus, but was most closely followed for its development of human embryonic stem cell-based retinal pigmented epithelial
Brief update from Bob Lanza on Astellas stem cell program Read More »
I’m working on an investigative story on fake news in the stem cell and regenerative medicine arena. Is there a growing stem cell fake news problem in the biotech world? More broadly, the SEC is cracking down on the mess that is fake biotech news, but what about publicly-traded stem cell biotechs more specifically? Already in the past
Ongoing story on stem cell fake news: send me your tips Read More »
Washington State is considering state funding for regenerative medicine. How cool is that? You can read more about this effort in an opinion piece authored by Washington stem cell researcher, Professor Charles Murry. There’s so much important stem cell research going on that federal funding, private and biotech investors, and philanthropy simply cannot fund it
Washington State considers stem cell regenerative medicine funding Read More »
Stem cell clinic biotech Stemedica has just been sued by one of its own board members based on allegations related to money the company raised, according to CourtHouseNews. The actual suit, filed by an investment company Tiara Holdings and board member Anthony Marlon, can be read here. CourtHouseNews writes: “Tiara Holdings II LLC sued Stemedica Cell
Stemedica sued by board member over alleged mishandling of funds Read More »
For me it’s been a wild week of grant and paper writing, grant review, going over data, and more, but finally I had a chance to watch this week’s Dr. Oz show on stem cell clinics in full last night and I give it an A+ grade. A show producer went undercover with an MS patient to a
Kudos to Dr. Oz for stellar stem cell clinic show: time for more action Read More »
In the whirlwind that is the stem cell and regenerative medicine world, there are many concerning things that need attention, but also good stuff happens too and this post focuses on the positive. The Asterias spinal cord injury clinical trial, a phase 1/2a trial called SCiStar, continues to make encouraging news with a clean safety profile
Good stem cell news on trials, FDA, cool new papers & more Read More »
Patient advocate Ted Harada is the recipient of this year’s Stem Cell Person of the Year Award. Congrats also to the runner-up, HD patient advocate Judy Roberson. The three of us together are pictured at left. You can read about the 20 nominees here and see the vote results that picked the 10 finalists here.
Stem Cell Person of the Year 2016: Patient Advocate Ted Harada Read More »